
Okeanis Eco Tankers Shares Trade Ex-Dividend $5.25
Okeanis Eco Tankers Corp. announced that its common shares will trade ex-dividend for USD 5.25 per common share. The ex-dividend date on the Oslo Stock Exchange is August 13, 2026, and on the New York Stock Exchange, it is August 14, 2026. This follows the Q2 2026 dividend announcement made on August 4, 2026.

Belite Bio's tinlarebant NDA Accepted by FDA with Priority Review
Belite Bio announced that the U.S. FDA accepted its New Drug Application (NDA) for tinlarebant for the treatment of Stargardt disease type 1 (STGD1) with Priority Review, setting a PDUFA target action date of February 12, 2027. The company also presented additional positive secondary endpoint data from its Phase 3 DRAGON trial, showing a marked divergence in quantitative autofluorescence between treatment and placebo groups. For Q2 2026, Belite Bio reported a net loss of $28.4 million, with increased R&D and SG&A expenses reflecting pipeline advancement and commercialization preparations.

Outlook Therapeutics Prices Public Offering at $0.99/Share
Outlook Therapeutics, Inc. announced the pricing of an underwritten public offering of 55,555,556 shares of its common stock and accompanying warrants. The combined public offering price is $0.99 per share and warrant, with warrants exercisable at $1.10 per share. The company expects to raise approximately $55.0 million in gross proceeds, which will be used to support the commercial launch of LYTENAVA™ in the United States, as well as for working capital and general corporate purposes. The offering is anticipated to close on August 14, 2026.

Global Water Resources Q2 Revenue Up 24.8% to $17.8M; Net Income $2.7M
Global Water Resources, Inc. reported strong Q2 2026 financial results, with total revenue increasing 24.8% to $17.8 million and net income rising to $2.7 million, or $0.10 per diluted share. This growth was primarily driven by unregulated revenue from infrastructure coordination and financing agreements (ICFA), the acquisition of seven water systems from Tucson Water, organic connection growth, increased consumption, and higher rates. The company also saw operational improvements, including a 5.8% increase in active service connections and a 6.1% rise in water consumption, alongside significant infrastructure investments and progress on rate case settlements.

Datacentrex Q2 Revenue $1.9M; GAAP Net Loss $5.5M; Net Cash Burn $61K
Datacentrex, Inc. reported financial results for the second quarter ended June 30, 2026, with revenue of $1.9 million, consistent with the prior year. The company posted a GAAP net loss of $5.5 million, primarily due to higher power costs and challenging digital asset market conditions. Despite these pressures, Datacentrex achieved a significant sequential improvement in Net Cash Burn to $61,000 and an improved Adjusted EBITDA loss of $1.3 million. The company ended the quarter with a strong liquidity position of $57.9 million in cash and digital assets and no debt.

Epsilon Energy Q2 Adjusted Net Income -$0.82M, EPS -$0.03
Epsilon Energy issued a corrected release for its second quarter 2026 financial and operating results, primarily due to recategorization of asset sale proceeds. The corrected Adjusted Net Income for Q2 2026 is -$815M, and Adjusted Net Income per share is -$0.03, significantly lower than previously stated. Despite the downward revision in adjusted profitability, the company reported strong year-over-year revenue growth of 57% to $18.26M and provided optimistic full-year 2026 production and capital expenditure guidance, reflecting ongoing operational transformation and project progress.

Bullish Launches First GFSC-Regulated Tokenized Equity Trading
Bullish announced that its tokenized shares (BLSH) have begun trading on Bullish Exchange, marking the first instance of tokenized equity trading on a Gibraltar Financial Services Commission (GFSC)-regulated digital asset exchange. This initiative establishes a regulated template for tokenized securities, offering direct share ownership and 24/7 trading with near-instant settlement. The launch is supported by GFSC approval received in June 2026 and is further enabled by Bullish's pending acquisition of Equiniti, a global transfer agent, expected to close in January 2027. Institutional participants like Wintermute are providing liquidity.

Dolphin Entertainment Q2 Net Loss Widens to $1.61M
Dolphin Entertainment, Inc. reported a widening net loss for the second quarter and first half of 2026, despite a modest increase in revenues. The company's net loss for Q2 2026 grew to $1.61 million from $1.41 million in Q2 2025, while year-to-date net loss reached $4.30 million compared to $3.74 million in the prior year. Revenues for the quarter increased by 2.5% to $14.44 million, and year-to-date revenues rose by 3.8% to $27.25 million, primarily driven by its Entertainment Publicity and Marketing segment. The company also saw a significant increase in cash used in operating activities and a decrease in total stockholders' equity.

Cabot Prices $350M Senior Unsecured Notes Due 2029 at 4.950%
Cabot Corporation announced the pricing of a public offering of $350 million of 4.950% senior unsecured notes due 2029. The notes were priced at 99.993% of their face amount, with interest payable semiannually. The company intends to use the net proceeds to repay its senior unsecured notes due September 2026, with the remainder allocated to working capital and general corporate purposes.

Core AI Holdings Launches $3.54M At-The-Market Offering
Core AI Holdings, Inc. has entered into a Market Issuance Sales Agreement with D. Boral Capital LLC to establish an "at the market offering" program. Under this program, the company can sell common shares for an aggregate offering price of up to $3,539,021. D. Boral will serve as the sales agent or principal, receiving a commission of 2.0% of the gross proceeds from shares sold.

CDT Equity Q2 Net Loss $4.64M; Going Concern Warning
CDT Equity Inc. reported a net loss of $4.64 million for the three months ended June 30, 2026, and $8.70 million for the six months ended June 30, 2026. The company issued a going concern warning, citing an accumulated deficit of $77.03 million and insufficient cash to fund its current business plan. Despite this, CDT Equity acquired a 20% equity interest in Sarborg for $123 million, significantly increasing total assets to $126.71 million.

American Express Issues New Series E Preferred Shares
American Express Company issued 1,600 shares of 6.450% Fixed Rate Reset Noncumulative Preferred Shares, Series E, represented by 1,600,000 Depositary Shares. The company also amended its Certificate of Incorporation to fix the terms of these new shares, which have a liquidation preference of $1,000,000 per share. Concurrently, American Express plans to redeem all Series D Preferred Shares and their associated Depositary Shares on September 15, 2026, at a price of $1,000 per Series D Depositary Share plus unpaid dividends.

Yorkville International Capital Reports Q2 Net Income $107,543 Post-IPO
Yorkville International Capital Corp. filed its 10-Q for the quarter ended June 30, 2026, reporting a net income of $107,543 for the period from its inception on March 31, 2026. The company, a Special Purpose Acquisition Company (SPAC), consummated its Initial Public Offering on June 17, 2026, raising $230,000,000, which was subsequently placed into a Trust Account. As of June 30, 2026, the company held $230,300,725 in its Trust Account and is focused on identifying and negotiating a potential Business Combination.

BioStem Uplists to Nasdaq; Q2 Revenue $7.9M, Raises FY26 Guidance
BioStem Technologies, Inc. announced its second quarter 2026 financial results, reporting net revenue of $7.9 million, a 29% sequential increase. The company also completed its uplisting to the Nasdaq Capital Market and secured a $2.5 million private placement. Despite the revenue growth and strategic milestones, BioStem reported a GAAP net loss of ($9.0) million and an Adjusted EBITDA loss of ($4.6) million for the quarter. Following these developments, the company raised its full-year 2026 revenue guidance to a range of $26 million to $29 million.

NewHold Enters Business Combination Agreement with NewCleo Ltd.
NewHold Investment Corp. III entered into a definitive Business Combination Agreement with NewCleo Ltd. on May 26, 2026, valuing NewCleo at a Base Equity Value of $2.35 billion. The company reported a net loss of $(3.35) million for the second quarter of 2026, contributing to an accumulated deficit of $(13.32) million. NewHold also disclosed substantial doubt about its ability to continue as a going concern, emphasizing the need to complete the Business Combination by March 3, 2027.







